High materiality9/10
TransMedics price target raised to $122 from $120 at Baird
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Baird raises TransMedics price target to $122 from $120. Current price $80.75. Price change since signal: +3.89.
Target: $122
Posted price: $80.75
Analyst firm: Robert W. Baird
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.